Cost-effectiveness model to evaluate 200-days vs 100-days treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (D+/R-) kidney transplant recipient in Spain
Data de publicación
2011Título da revista
TRANSPLANT INTERNATIONAL
Tipo de contido
Publicación de congreso